Tandem Diabetes Care (TNDM) Change in Accured Expenses (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Change in Accured Expenses for 14 consecutive years, with -$2.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses fell 319.92% year-over-year to -$2.3 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 million (down 81.87% YoY), and the FY2025 full-year result was $6.0 million, down 71.26% from the prior year.
• Change in Accured Expenses climbed to -$2.3 million in Q2 2026 per TNDM's latest filing, from -$14.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $15.8 million in Q3 2024 and bottomed at -$40.9 million in Q4 2022.
• Historically, Change in Accured Expenses has averaged $115555.6 across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses slumped 1042.99% in 2022, then soared 112485.71% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$40.9 million in 2022, then jumped by 99.01% to -$404000.0 in 2023, then surged by 1475.99% to $5.6 million in 2024, then climbed by 4.3% to $5.8 million in 2025, then sank by 140.17% to -$2.3 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$2.3 million, -$14.7 million, and $5.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.